Toronto Psoriatic Arthritis Screening (TOPAS2) Questionnaire
- Technology Application
- Patient assessmentand stratification for clinical trial
- Detailed Technology Description
- A clinical tool to identifypsoriatic arthritic patients
- *Abstract
-
The Toronto Psoriatic Arthritis Screeningquestionnaire (ToPAS2) was developed as a tool to screen for psoriaticarthritis (PsA) in patients with psoriasis as well as in the generalpopulation. Thus, it differs from PsA-specific screening tools and may be usedto screen for PsA in epidemiologic and family investigations.
- *Principal Investigator
-
Dr.Vinod Chandran andDr. Dafna D Gladman
- *Publications
- J Rheumatol. 2015May;42(5):841-6. doi: 10.3899/jrheum.140857. Epub 2015 Apr 1. Validation of theToronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). Tom BD1, Chandran V1,Farewell VT1, Rosen CF1, Gladman DD2.
- Country/Region
- USA
For more information, please click Here

